Allegra, A.; Cancemi, G.; Mirabile, G.; Tonacci, A.; Musolino, C.; Gangemi, S.
Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma. Cancers 2022, 14, 4136.
https://doi.org/10.3390/cancers14174136
AMA Style
Allegra A, Cancemi G, Mirabile G, Tonacci A, Musolino C, Gangemi S.
Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma. Cancers. 2022; 14(17):4136.
https://doi.org/10.3390/cancers14174136
Chicago/Turabian Style
Allegra, Alessandro, Gabriella Cancemi, Giuseppe Mirabile, Alessandro Tonacci, Caterina Musolino, and Sebastiano Gangemi.
2022. "Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma" Cancers 14, no. 17: 4136.
https://doi.org/10.3390/cancers14174136
APA Style
Allegra, A., Cancemi, G., Mirabile, G., Tonacci, A., Musolino, C., & Gangemi, S.
(2022). Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma. Cancers, 14(17), 4136.
https://doi.org/10.3390/cancers14174136